Literature DB >> 2785755

Direct current electrotherapy of internal hemorrhoids: an effective, safe, and painless outpatient approach.

D A Norman1, R Newton, G V Nicholas.   

Abstract

Hemorrhoid disease is one of the most frequently occurring, disabling conditions of man. We report the results of 120 patients with symptomatic internal and mixed hemorrhoid disease treated with direct current (d.c.) via a dual-tipped disposable needle probe (negative electrode). Evaluation and treatment utilized an operative anoscope which visualized one-eighth of the anal canal. Five hundred ninety segments revealed hemorrhoid disease (grade 1 = 114, 2 = 222, 3 = 178, 4 = 76). One or more segments (highest grade) were treated per office visit. Symptoms, frequency, and mean number of treatment applications per patient for complete symptom resolution were: bleeding, 85%, 4.0; protrusion, 58%, 3.9; pain, 52%, 3.6; and pruritus, 49%, 3.9. Ablation of hemorrhoid disease grade was directly correlated with milliampere current and time of application. No major complications occurred. All patients were successfully treated and remained symptom-free at a mean duration of follow-up of 23 months. Direct current electrotherapy is an effective, painless, and safe outpatient treatment approach to all grades of internal and mixed hemorrhoid disease.

Entities:  

Mesh:

Year:  1989        PMID: 2785755

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

Review 1.  Treatment of fissure in ano- revisited.

Authors:  Pravid J Gupta
Journal:  Afr Health Sci       Date:  2004-04       Impact factor: 0.927

Review 2.  Diagnosis and management of lower gastrointestinal bleeding.

Authors:  Jürgen Barnert; Helmut Messmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

3.  Direct current electrotherapy for internal haemorrhoids: experience in a tertiary health institution.

Authors:  Samuel Olatoke; Moses Adeoti; Olayide Agodirin; Abdulwahab Ajape; John Agbola
Journal:  Pan Afr Med J       Date:  2014-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.